CME Group Inc. (NASDAQ:CME – Get Free Report) CEO Terrence Duffy sold 27,000 shares of the business’s stock in a transaction that occurred on Wednesday, November 18th. The stock was sold at an average price of $309.57, for a total transaction of $8,358,390.00. Following the transaction, the chief executive officer owned 35,442 shares of the company’s stock, valued at approximately $10,971,779.94. This trade represents a 43.24% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink.
CME Group Stock Performance
Shares of NASDAQ:CME traded down $3.94 during trading on Thursday, hitting $306.31. 2,451,943 shares of the stock traded hands, compared to its average volume of 2,467,037. The company has a fifty day moving average price of $288.15 and a two-hundred day moving average price of $281.93. The company has a market cap of $109.64 billion, a price-to-earnings ratio of 25.13, a P/E/G ratio of 3.80 and a beta of 0.15. CME Group Inc. has a 52-week low of $218.31 and a 52-week high of $329.16. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.13.
CME Group (NASDAQ:CME – Get Free Report) last announced its earnings results on Wednesday, October 21st. The financial services provider reported $3.02 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.99 by $0.03. CME Group had a net margin of 63.33% and a return on equity of 16.23%. The business had revenue of $1.74 billion for the quarter, compared to analyst estimates of $1.71 billion. During the same quarter last year, the business earned $2.68 earnings per share. The company’s revenue for the quarter was up 10.6% compared to the same quarter last year. As a group, equities analysts predict that CME Group Inc. will post 12.35 EPS for the current year.
CME Group Announces Dividend
The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 30th. Stockholders of record on Friday, December 11th will be paid a $1.30 dividend. The ex-dividend date of this dividend is Friday, December 11th. This represents a $5.20 annualized dividend and a dividend yield of 1.7%. CME Group’s dividend payout ratio (DPR) is presently 42.66%.
Institutional Investors Weigh In On CME Group
A number of hedge funds have recently added to or reduced their stakes in CME. First Community Trust NA acquired a new position in shares of CME Group in the 3rd quarter worth approximately $26,000. North Point Portfolio Managers Corp OH acquired a new position in shares of CME Group during the 3rd quarter valued at about $26,000. Tanglewood Legacy Advisors LLC bought a new stake in shares of CME Group during the 3rd quarter worth $26,000. Mowery & Schoenfeld Wealth Management LLC acquired a new stake in shares of CME Group in the second quarter valued at about $28,000. Finally, Compass Financial Management LLC boosted its position in shares of CME Group by 471.4% in the third quarter. Compass Financial Management LLC now owns 120 shares of the financial services provider’s stock valued at $31,000 after acquiring an additional 99 shares during the period. 87.75% of the stock is currently owned by institutional investors.
Analyst Upgrades and Downgrades
CME has been the subject of several research analyst reports. JPMorgan Chase & Co. upgraded shares of CME Group from an “underweight” rating to an “overweight” rating and set a $367.00 price objective for the company in a research note on Thursday, October 22nd. Barclays lifted their target price on CME Group from $281.00 to $321.00 and gave the company an “equal weight” rating in a research note on Thursday, October 22nd. TD Cowen upped their price target on CME Group from $292.00 to $300.00 and gave the stock a “buy” rating in a research note on Monday, October 5th. UBS Group upped their price objective on shares of CME Group from $270.00 to $310.00 and gave the stock a “neutral” rating in a research report on Thursday, October 22nd. Finally, Weiss Ratings upgraded shares of CME Group from a “buy (b)” rating to a “buy (b+)” rating in a research report on Friday, November 13th. Ten research analysts have rated the stock with a Buy rating, six have assigned a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, CME Group currently has a consensus rating of “Hold” and a consensus target price of $314.44.
Check Out Our Latest Stock Report on CME
CME Group Company Profile
CME Group operates a global marketplace for derivatives and other financial products. Through its exchanges—CME, CBOT, NYMEX and COMEX—it offers futures and options contracts tied to interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The company also provides clearing and settlement services, market data and related products. Its electronic trading platform, CME Globex, supports access to its markets by participants around the world, alongside its open-outcry and privately negotiated trading services.
Recommended Stories
- Five stocks we like better than CME Group
- Grand Theft Auto VI Arrives: Why Take-Two Is a Waiting Game
- Greg Abel Makes His Next Moves: Inside Berkshire’s Q3 Portfolio
- Walmart Earnings Change the Narrative as Digital Growth Lifts Outlook
- Whatever Happens to Copper Next, These 3 Investments Offer Different Ways to Play It
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
